- ►annals.org RW Shafer, MA Winters, S Palmer, TC … - Annals of internal …, 1998 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Background: Drug resistance of
HIV-1 is an obstacle to the long-term efficacy of antiretroviral therapy. Cited by 170 - Related articles - BL Direct - All 6 versions
S Palmer, RW Shafer, TC Merigan - AIDS (London, England), 1999 - pubmedcentral.nih.gov Requests for reprints to: (present address) Dr Sarah Palmer, Research Virologist, Southern Research
Institute, 431 Aviation Way, Frederick, MD 21701, USA. Tel: +1-301-228-2171; fax:
+1-301-694-2797. ... The publisher's final edited version of this article is available at AIDS. Cited by 102 - Related articles - BL Direct - All 5 versions
K Hertogs, S Bloor, SD Kemp, CV Eynde, TM Alcorn, R … - Aids, 2000 - journals.lww.com Objective: To evaluate in HIV-1 the extent of phenotypic and genotypic antiretroviral drug resistance
and cross-resistance towards the protease inhibitors (PIs) saquinavir, ritonavir, indinavir and
nelfinavir among a set of patient samples originating from European and US routine ... Cited by 147 - Related articles - BL Direct - All 4 versions
- ►nih.gov [PDF] JH Condra, DJ Holder, WA Schleif, OM Blahy, … - The Journal of …, 1996 - jvi.highwire.org Page 1. J OURNAL OF V IROLOGY , Dec. 1996, p. 8270–8276 Vol. 70, No. 12 0022-538X/96/
$04.00 0 Copyright 1996, American Society for Microbiology Genetic Correlates of In Vivo Viral
Resistance to Indinavir, a Human Immunodeficiency Virus Type 1 Protease Inhibitor ... Cited by 329 - Related articles - BL Direct - All 7 versions
S PALMER, A ALAEUS, JAN ALBERT, S … - AIDS research and human …, 1998 - liebertonline.com Page 1. AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 14, Number
2, 1998 Mary Ann Liebert, Inc. Drug Susceptibility of Subtypes A, B, C, D, and E
Human Immunodeficiency Virus Type 1 Primary Isolates SARAH ... Cited by 107 - Related articles - BL Direct - All 4 versions
- ►nih.gov AK Patick, M Duran, Y Cao, D Shugarts, MR … - Antimicrobial agents …, 1998 - aac.highwire.org Nelfinavir mesylate (formerly AG1343) is a potent and selective inhibitor of human immunodeficiency
virus (HIV) protease approved for the treatment of individuals infected with HIV. Nucleotide sequence
analysis of protease genes from plasma HIV type 1 (HIV-1) RNA revealed a unique ... Cited by 161 - Related articles - BL Direct - All 7 versions
- ►nih.gov J Martinez-Picado, AV Savara, L Sutton, RT D' … - Journal of virology, 1999 - Am Soc Microbiol The relative replicative fitness of human immunodeficiency virus type 1 (HIV-1) mutants selected
by different protease inhibitors (PIs) in vivo was determined. Each mutant was compared to wild
type (WT), NL4-3, in the absence of drugs by several methods, including clonal ... Cited by 291 - Related articles - BL Direct - All 9 versions
P Lorenzi, M Opravil, B Hirschel, JP Chave, HJ Furrer, … - Aids, 1999 - journals.lww.com From the AIDS Centre, Geneva University Hospital, Geneva, the *Division of Infectious
Diseases, Zurich University Hospital, Zurich, † Ch. Porchat 24, Lausanne, the ‡ AIDS Unit, University
Hospital, Bern, the § Institute of Social and Preventive Medicine, and the ¶ Laboratory of ... Cited by 167 - Related articles - BL Direct - All 4 versions
